🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase II, randomized, double-blind, placebo-controlled study of the safety ...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2018-10-15
Trial ID
NCT04133987
Treatments Being Tested
Primary Objective: To evaluate the safety of CYD-TDV in pregnant women and...
Status
Completed
Location
Universidade Federal do Paraná Site Number : 1
Start Date
2022-03-11
Trial ID
NCT04023708
Treatments Being Tested
This study will evaluate the safety and immunogenicity of a tetravalent den...
Status
Completed
Location
Center for Immunization Research, Johns Hopkins School of Public Health
Start Date
2016-02-01
Trial ID
NCT02879266
Treatments Being Tested
The purpose of this study was to demonstrate that V181 is safe and well tol...
Status
Completed
Location
Hospital Tacchini (Site 0006)
Start Date
2023-02-15
Trial ID
NCT05710224
Treatments Being Tested
This study used 3 different formulations of tetravalent CYD dengue vaccine....
Status
Completed
Location
Investigational Site 004
Start Date
2008-04-17
Trial ID
NCT00617344
The purpose of this study is to investigate lot-to-lot consistency in terms...
Status
Completed
Location
Optimal Research
Start Date
2018-02-12
Trial ID
NCT03423173
Infants aged 9 months will be randomized to receive a meningococcal vaccine...
Status
Completed
Location
Centre pour le Developpement des Vaccins du Mali
Start Date
2022-03-24
Trial ID
NCT05093829
Treatments Being Tested
To evaluate effect of previous flavivirus exposure on the safety and immuno...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00730288
This is one project of a larger ongoing study related to the immune system'...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2019-10-08
Trial ID
NCT03898986
Treatments Being Tested
The main purpose of this Phase II study was to assess the safety and immuno...
Status
Completed
Location
Investigational Site Number :8400003
Start Date
2021-07-16
Trial ID
NCT04969276
Treatments Being Tested